Background. As survival with an orthotopic liver transplant (OLT) improves, the incidence of chronic kidney disease in OLT recipients increases. Measurement of kidney function using creatinine-based estimates is often inaccurate, while cystatin C may overcome the biases that effect creatinine. The aim of this study was to assess the accuracy of creatinine-and cystatin C-based equations to estimate kidney function in long-term OLT recipients. Methods. This was a cross-sectional study performed on OLT recipients within a single liver transplant centre where creatinine (n = 41) and cystatin C (n = 30) were measured and glomerular filtration rate (GFR) estimated using the Modification of Diet and Renal Disease (MDRD), Cockcroft-Gault (CG), Hoek, Larsson, Filler and Le Bricon equations. Comparison was made with the nuclear GFR (nGFR) (n = 41) measured through 51-Cr EDTA clearance. Results. The mean age of recipients was 56 ± 13 years, and they were 6.5 ± 4.7 years post-OLT. Fifty-six percent of recipients had a nGFR ≤60 mL/min/1.73 m 2 . nGFR correlated significantly with all predictive equations (P < 0.001). The MDRD, CG and Le Bricon equations had the smallest degree of bias (−7.6, −7.3 and 3.4 mL/min/1.73 m 2 , respectively), with 22%, 22% and 27% of estimates, respectively, being within 10% of nGFR measurements. In OLT recipients with nGFR ≤60 mL/min/1.73 m 2 , the degree of bias of both the creatinine-base MDRD and cystatinbased Hoek equations was within 2 mL/min/1.73 m 2 difference between the measured and estimated GFR, but 41% and 36% of estimates were within 10% of the nGFR measurement. Conclusions. Therefore, the degree of inaccuracy in cystatin C-and creatinine-based predictive equations brings into question their clinical utility in OLT recipients. We have no evidence that cystatin C is superior to creatinine in this population.
Introduction
Chronic kidney disease (CKD) following orthotopic liver transplantation (OLT) is becoming an increasing problem as patient and graft survival following OLT improves. The 1-, 5-and 8-year graft survival following OLT is currently estimated at 85%, 70% and 62%, respectively [1, 2] . Recent data indicate that the incidence of CKD following OLT is 18% after 5 years and 26% after 10 years [3, 4] . End-stage kidney disease (ESKD) requiring dialysis or kidney transplantation occurs in 9.5% of patients 13 years following OLT, and these patients had a 28% 13-year survival compared to 55% in the control group [3, 4] .
The aetiology of CKD is multifactorial in nature with nephrotoxicity secondary to calcineurin inhibitors probably playing a major role [3] [4] [5] . CKD leads to significant complications, with an increased incidence of morbidity and mortality [3, 4] . ESKD results in considerable cost and an annual mortality of up to 20% [6] .
Kidney function is most commonly estimated using serum creatinine-based equations. In the context of chronic liver disease, however, creatinine has been shown to overestimate kidney function due to poor muscle bulk, impaired creatinine biosynthesis and hyperbilirubinaemia [7] [8] [9] . Hence, equations that utilize serum creatinine to estimate glomerular filtration rate (GFR) in chronic liver disease patients are prone to error [7] [8] [9] .
The gold standard method of estimation of kidney function is with inulin clearance or nuclear medicine tests [10] . These, however, are not practical for usual clinical practice due to their complexity and cost. Creatinine clearance using 24-h urine collection is also prone to measurement error due to difficulties with collection [11] .
Cystatin C, a low-molecular-weight (∼13.3 kD) protease inhibitor, is produced at a constant rate in all nucleated cells [12, 13] . It is freely filtered in the glomerulus where it is then fully reabsorbed in the proximal tubule and catabolized. Its level is unaffected by muscle bulk, age and gender. For these reasons, recent evidence suggests that it may provide a more accurate estimate of kidney function, especially through the use of predictive equations [13] [14] [15] [16] . Our aim was to investigate further the accuracy of creatinine-and cystatin C-based predictive equations for estimating GFR in long-term OLT patients. Patients that were recipients of multi-organ transplants were not recruited. All patients were over the age of 18 years and had an OLT for at least 3 months. Patient information was collected including demographic data, indication for transplantation, transplant date, immunosuppression regimen and hepatitis B and C status. Blood tests were performed on the same day as nuclear GFR (nGFR) was measured.
Subjects and methods
Creatinine was measured using a kinetic colourimetric assay (Jaffe method) analysed on the Roche Hitachi 917 analyser (Roche Diagnostic GmbH, Mannheim, Germany). Total coefficients of variation (cv) for this assay are 6.6% at 70.5 µmol/L and 4.1% at 485 µmol/L. The assay used was calibrated with an IDMS reference laboratory. Cystatin C was measured on the same day as the nGFR was performed, using particleenhanced immunonephelometry run on the BNII analyser (Dade Boehring GmbH, Marbug, Germany). The total cv for this assay are 4.0% at 0.44 mg/L and 5.3% at 0.76 mg/L. nGFR was estimated through the injection of 3.0 megabequerels of radioactive 51 Cr-ethylenediaminetetraacetic acid (EDTA). Blood samples were obtained 1, 2 and 3 h later for a total of three blood samples. 51 Cr-EDTA clearance was then calculated and corrected for body surface area.
GFR was estimated from serum creatinine utilizing the Modification of Diet in Renal Disease (MDRD) [17] study and Cockcroft-Gault equations (Table 1) [18, 19] . In addition, GFR was estimated from cystatin C using the equations validated by Hoek [19] , Larsson [20] , Filler [21] and Le Bricon [22] . Because MDRD-GFR has been shown to have a poor correlation with nGFR at values >60 mL/min/1.73 m 2 , a separate analysis was done for correlations between creatinine-and cystatin-based equations and nGFR for values below and above 60 mL/min/1.73 m 2 by EDTA clearance [23] .
Statistical analysis
Results are expressed as mean ± standard deviation, unless otherwise stated. Linear regression was utilized to compare the inverse of creatinine, inverse of cystatin C and GFR predictive equations with nGFR. Spearman's rank correlation was used instead of linear regression if the assumptions of normality of residuals and homoscedasticity were not met. To estimate the reliability of the GFR equations, the difference in nGFR indicated the bias, while the standard deviation of the difference indicated precision [24] . Accuracy in this article is used to quantify the combination of bias and precision. Participants were divided into two groups based upon nGFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2 . STATA 8.2 (Stata Corporation, College Station, TX, USA) was used for the analysis. 
Results
Forty-one OLT recipients participated in this study with measurements of nGFR and serum creatinine. Thirty subjects also had serum cystatin C measured. The mean time since transplantation was 6.5 ± 4.7 years ( Table 2 ). The cause of liver failure included autoimmune liver disease in 44%, viral hepatitis in 29%, alcohol in 7% and other causes in 20% of subjects. The standard immunosuppression regimens at the time of transplantation were prednisolone, azathioprine and calcineurin inhibitors (cyclosporine or tacrolimus). Current immunosuppression included 68% on dual therapy with 61% on cyclosporine and 27% on tacrolimus. The mean spot urine protein:creatinine was 14.3 ± 9.5 mg/mmol (range 3.6-55.4 mg/mmol).
On nGFR, the mean was 58.0 ± 19.8 mL/min/1.73 m 2 (range 19.3-121 mL/min/1.73 m 2 ) and 56% of participants had a nGFR ≤ 60/mL/min/1.73 m 2 . All creatinine-based and cystatin-based equations correlated significantly with nGFR ( Table 3 ). The inverse of creatinine (R 2 = 0.44) and cystatin (R 2 = 0.64) also correlated significantly with nGFR, P ≤ 0.0001. In the entire population, the MDRD equation correlated best with nGFR on linear regression analysis (R 2 = 0.62, P < 0.0001). The cystatin-based equations all correlated closely with nGFR, with the Filler equation performing the most poorly (R 2 = 0.32, P = 0.001).
The MDRD, Cockcroft-Gault and Le Bricon equations featured the smallest degree of bias, −7.6, −7.3 and 3.4 mL/min/1.73 m 2 , respectively (Table 4 ). In addition, the MDRD and Le Bricon equations resulted in 80% of estimated GFRs in OLT recipients being within 30% of the nGFR. The cystatin C-based Filler equation performed the most poorly, underestimating the nGFR by a median of 23.5 mL/min/1.73 m 2 . This formula also only managed to estimate the GFR within 30% of the nGFR in 23% of patients.
Almost all predictive equations performed better in OLT recipients with a nGFR <60 mL/min/1.73 m 2 ( Table 4 ). The equations with the smallest degree of bias in those patients with a GFR <60 mL/min/1.73 m 2 were the MDRD (−1.7 mL/min/1.73 m 2 ) and Hoek equations (0.98 mL/min/ 1.73 m 2 ) (Figure 1 ).
Discussion
For a multitude of reasons, including improved long-term survival, OLT recipients are developing problems with the increase of CKD [1] [2] [3] [4] . CKD alone leads to increased morbidity and mortality that is magnified in its severest manifestation of ESKD [6, 25] . There are interventions available that may allow a degree of protection against progressive kidney failure, including the avoidance of nephrotoxic calcineurin inhibitors [5] . Thus, early detection and ongoing monitoring of those patients with a progressive loss of GFR would allow OLT recipients to benefit from interventions.
One of the major issues in the management of CKD in OLT recipients is the overestimation of creatinine-based predictive equations for GFR [7] [8] [9] . Cystatin C is not influenced by many of the factors that usually affect creatinine concentrations in OLT recipients. As such cystatin C-based predictive equations for GFR have been suggested to be more accurate in this patient population [26] [27] [28] [29] .
The results of our study demonstrate that, in our cohort, both creatinine-and cystatin C-based estimations of kidney function correlated significantly with nGFR. The creatinine-based MDRD equation and the cystatin C-based Le Bricon equation displayed the least bias and greatest precision of all the formulas examined, underestimating the 'true' GFR by ∼4-8 mL/min/1.73 m 2 on average. The accuracy even with these formulae was, however, poor, with only 22% and 27%, respectively, estimating the GFR within 10% of the nGFR measurements. The accuracy of these equations was improved when it was restricted to OLT recipients with a nGFR <60 mL/min/1.73 m 2 . Even in this subgroup, the clinical utility of these equations, in view of the degree of inaccuracy, is questionable. A limitation of this study is the small sample size, which reduces the ability to detect differences between equations.
The only other published study to date comparing creatinine and cystatin C predictive equations with nGFR in long-term OLT recipients examined 59 adults with a mean of 5.1 ± 3.0 years post-transplant [30] . They used the Hoek, Filler and Larson cystatin C equations and the MDRD equation to estimate GFR and compared it to nGFR, measured by 99 mTc-diethylene triamine pentaacetic acid clearance. The correlation was similar between formulae and similar to our results. The bias was lowest with the Hoek and Larsson formulae, underestimating the nGFR by 0.1 and 2.3 mL/min/1.73 m 2 (P = not significant). The Hoek equation had the greatest accuracy with 76.3% of estimations being within 30% of the nGFR, though this was not significantly different to the MDRD equation (64.4%). These findings are consistent with ours, except that the Le Bricon equation was not examined.
Schuk et al. examined 58 adult OLT recipients with a mean of 14 ± 10 months post-transplant and measured GFR with inulin clearance [29] . They concluded that cystatin C levels <1.2 mg/L excluded mild reductions in GFR, with cystatin C having significantly greater sensitivity than creatinine. The only other study to use nGFR and compare it with cystatin C and creatinine concentration examined 62 paediatric OLT recipients with a median of 3.1 years post-transplant had similar findings [28] . Neither study examined cystatin C predictive equations.
Other studies that have compared cystatin C with creatinine in long-term OLT recipients had similar inconsistent findings with two demonstrating superiority of cystatin C and the other one showing equivalence [26, 27, 31] . These studies did not use nGFR or creatinine clearance as a comparator.
A study in kidney transplant recipients demonstrated a similar accuracy to our study of creatinine-based formula, with 53-80% of recipients estimating within 30% of the nGFR [24] . However, they found that the Filler and Le Bricon equations were superior with a bias of −1.7 and 3.8 mL/min/1.73 m 2 , precision of 11.4 and 11.8 mL/min/1.73 m 2 and with 87 and 89% of estimates within 30% of the nGFR measurements [24] . On the other hand, similar to our findings, Poge et al. did not demonstrate any difference between the MDRD equation and cystatin C compared to nGFR in kidney transplant recipients [32] .
Accurate estimation of kidney function is of increasing importance in OLT recipients as survival improves. We have shown that creatinine-and cystatin C-based equations vary in their bias and precision in estimating GFR. Even though these equations are improved in OLT recipients with a GFR <60 ml/min/1.73 m 2 , the degree of inaccuracy places doubt over the utility of these equations in clinical practice. There is no evidence in our data that cystatin C is superior to MDRD, and in view of the added expense its use cannot be recommended at this stage.
